The risks and benefits of influenza H5N1 research
Both Nature and the New York Times have weighed in on the resumption of influenza H5N1 research. In an editorial from 23 January 2013, Nature opines that “Experiments that make deadly pathogens more dangerous demand the utmost scrutiny”: As several critics point out, the assessments of the relative risks and benefits of such research remain …
The risks and benefits of influenza H5N1 research Read More »